- Home
- AXSM vs HUN Comparison
AXSM vs HUN Comparison
Compare AXSM & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | HUN |
|---|---|---|
| Founded | 2012 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 1.7B |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | AXSM | HUN |
|---|---|---|
| Price | $152.16 | $10.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 11 |
| Target Price | ★ $176.00 | $10.23 |
| AVG Volume (30 Days) | 464.4K | ★ 4.7M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 3.47% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $561,263,000.00 | ★ $5,780,000,000.00 |
| Revenue This Year | $66.40 | N/A |
| Revenue Next Year | $56.13 | $3.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 65.83 | N/A |
| 52 Week Low | $75.56 | $7.30 |
| 52 Week High | $158.57 | $18.53 |
Technical Indicators
Market Signals| Indicator | AXSM | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 54.46 |
| Support Level | $152.41 | $9.84 |
| Resistance Level | $158.56 | $10.32 |
| Average True Range (ATR) | 4.13 | 0.44 |
| MACD | 0.08 | -0.09 |
| Stochastic Oscillator | 55.41 | 25.00 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.